Skip to content

Amber M Leaver

5 papers in the library · 162 citations · publishing 2016-2024

Papers

Sort Most recent Most cited

Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.

Brain and Behavior June 1, 2024 Brandon Taraku, Joana R Loureiro, Ashish K Sahib et al. 11 citations

Major depressive disorder (MDD) is associated with dysfunctional reward processing, which involves functional circuitry of the habenula (Hb) and nucleus accumbens (NAc). Since ketamine elicits rapid antidepressant and antianhedonic effects in MDD, this study sought to investigate how serial ketamine infusion (SKI) treatment modulates static and dynamic functional connectivity (FC) in Hb and NAc...

Ketamine treatment modulates habenular and nucleus accumbens static and dynamic functional connectivity in major depression

medRxiv Preprint Server December 1, 2023 Brandon Taraku, Joana R Loureiro, Ashish K Sahib et al. 1 citation preprint

Dysfunctional reward processing in major depressive disorder (MDD) involves functional circuitry of the habenula (Hb) and nucleus accumbens (NAc). Ketamine elicits rapid antidepressant and alleviates anhedonia in MDD. To clarify how ketamine perturbs reward circuitry in MDD, we examined how serial ketamine infusions (SKI) modulate static and dynamic functional connectivity (FC) in Hb and NAc...

Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine

Biological Psychiatry Cognitive Neuroscience and Neuroimaging November 25, 2022 Artemis Zavaliangos-Petropulu, Noor B. Al-Sharif, Brandon Taraku et al. 27 citations

Major depressive disorder is a highly prevalent psychiatric disorder. Despite an extensive range of treatment options, about a third of patients still struggle to respond to available therapies. In the last 20 years, ketamine has gained considerable attention in the psychiatric field as a promising treatment of depression, particularly in patients who are treatment resistant or at high risk for...

Modulation of amygdala reactivity following rapidly acting interventions for major depression.

Human Brain Mapping May 1, 2020 Joana R Loureiro, Amber M Leaver, Megha M Vasavada et al. 65 citations

Electroconvulsive therapy (ECT) and ketamine treatment both induce rapidly acting antidepressant effects in patients with major depressive disorder unresponsive to standard treatments, yet their specific impact on emotion processing is unknown. Here, we examined the neural underpinnings of emotion processing within and across patients (N = 44) receiving either ECT (N = 17, mean age: 36.8, 11.0...

Structural connectivity and response to ketamine therapy in major depression: A preliminary study.

Journal of Affective Disorders January 15, 2016 Megha M Vasavada, Amber M Leaver, Randall Espinoza et al. 58 citations

Ketamine elicits an acute antidepressant effect in patients with major depressive disorder (MDD). Here, we used diffusion imaging to explore whether regional differences in white matter microstructure prior to treatment may predict clinical response 24h following ketamine infusion in 10 MDD patients. FSL's Tract-Based Spatial Statistics (TBSS) established voxel-level differences in fractional...